1. World Health Organization et al. Global report on diabetes. – World Health Organization, 2016. Global report on diabetes [Electronic resource]: URL: http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf. (Date accessed20.12.2018)
2. American Diabetes Association et al. Diagnosis and classification of diabetes mellitus. Diabetes care. 2014. Vol. 37. No Supplement 1. pp. S81-S90. DOI: 10.2337/dc14-S081
3. Friedman M. Mushroom polysaccharides: chemistry and antiobesity, antidiabetes, anticancer, and antibiotic properties in cells, rodents, and humans. Foods. 2016. Vol. 5. No. 4 (80). pp. 1-40. DOI: 10.3390/foods5040080
4. Jayachandran M., Xiao J., Xu B. A critical review on health promoting benefits of edible mushrooms through gut microbiota. International journal of molecular sciences. 2017. Vol. 18. No. 9. p. 1934. DOI: 10.3390/ijms18091934
5. Wasser S. Medicinal mushroom science: Current perspectives, advances, evidences, and challenges. Biomedical journal. 2014. Vol. 37. No. 6. pp. 345-356. DOI: 10.4103/2319-4170.138318
6. Su C.H. et al. Comparative characterization of physicochemical properties and bioactivities of polysaccharides from selected medicinal mushrooms. Applied microbiology and biotechnology. 2016. Vol. 100. No. 10. pp. 4385-4393.
7. Chang C J. et al. Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nature communications. 2015. Vol. 6. p. 7489.
8. Kundakovic T., Kolundzic M. Therapeutic properties of mushrooms in managing adverse effects in the metabolic syndrome. Current Topics in Medicinal Chemistry. 2013. Vol. 13. No. 21. pp. 2734-2744. DOI: 10.2174/15680266113136660196
9. Lo H.C., Wasser S.P. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems. International journal of medicinal mushrooms. 2011. Vol. 13. No. 5. pp.401-426. DOI: 10.1615/IntJMedMushr.v13.i5.10
10. Neyrinck A.M. et al. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin–glucan fiber improves host metabolic alterations induced by high-fat diet in mice. The Journal of nutritional biochemistry. 2012. Vol. 23. No. 1. pp. 51-59. DOI: 10.1016/j.jnutbio.2010.10.008
11. Bashir K.M., Choi J.S. Clinical and physiological perspectives of β-glucans: The past, present, and future. International journal of molecular sciences. 2017. Vol. 18(9). pp. 1906. DOI: 10.3390/ijms18091906
12. W.J.A. Banukie N. Jayasuriya et al. Hypoglycaemic activity of culinary Pleurotus ostreatus and P. cystidiosus mushrooms in healthy volunteers and type 2 diabetic patients on diet control and the possible mechanisms of action. Phytotherapy research. 2015. Vol. 29. No. 2. pp. 303-309. DOI: 10.1002/ptr.5255
13. Sohn J.H. et al. Effects of β-glucan and Folium mori extract combinations in STZ-induced diabetic rats: Effectiveness of various BGFM complex compositions in treating diabetes. Current Nutrition & Food Science. 2018. Vol. 14. No. 3. pp. 235-246. DOI: 10.2174/1573401313666170609094842
14. Yamac M. et al. Hypoglycemic effect of Lentinus strigosus (Schwein.) Fr. crude exopolysaccharide in streptozotocin-induced diabetic rats. Journal of medicinal food. 2008. Vol. 11. No. 3. pp. 513-517. DOI: 10.1089/jmf.2007.0551
15. Li J. P., Lei Y., Zhan H. The effects of the king oyster mushroom Pleurotus eryngii (higher Basidiomycetes) on glycemic control in alloxan-induced diabetic mice. International journal of medicinal mushrooms. 2014. Vol. 16. No. 3. pp. 219-225. DOI: 10.1615/IntJMedMushr.v16.i3.20
16. Wang Y. et al. Agaricus bisporus lectins mediates islet β-cell proliferation through regulation of cell cycle proteins. Experimental Biology and Medicine. 2012. Vol. 237. No. 3. pp. 287-296. DOI: 10.1258/ebm.2011.011251
17. Cao Y. et al. Hypoglycemic activity of the Baker's yeast β‐glucan in obese/type 2 diabetic mice and the underlying mechanism. Molecular nutrition & food research. 2016. Vol. 60. No. 12. pp. 2678-2690. DOI: 10.1002/mnfr.201600032
18. Wang P. C. et al. Anti-diabetic polysaccharides from natural sources: A review. Carbohydrate polymers. 2016. Vol. 148. pp. 86-97. DOI: 10.1016/j.carbpol.2016.02.060
19. Vitak T. et al. Effect of medicinal mushrooms on blood cells under conditions of diabetes mellitus. World journal of diabetes. 2017. Vol. 8. No. 5. pp. 187-201. DOI: 10.4239/wjd.v8.i5.187
20. Luna B., Feinglos M.N. Oral agents in the management of type 2 diabetes mellitus. American family physician. 2001. Vol. 63. No. 9. pp. 1747-1756. PMID:11352285
21. Bhaskar D. et al. Effect of β-glucan fortification on physico-chemical, rheological, textural, colour and organoleptic characteristics of low fat dahi.Journal of food science and technology. 2017. Vol. 54. No. 9. pp. 2684-2693. DOI: 10.1007/s13197-017-2705-6
22. Raikos V. et al. Use of β-glucan from spent brewer's yeast as a thickener in skimmed yogurt: Physicochemical, textural, and structural properties related to sensory perception. Journal of dairy science. 2018. Vol. 101. No 7. pp. 5821-5831. DOI: 10.3168/jds.2017-14261
23. Khorshidian N. et al. An overview of β-Glucan functionality in dairy products. Current Nutrition & Food Science. 2018. Vol. 14. No. 4. pp. 280-292. DOI: 10.2174/1573401313666170609092748
24. Giavasis I. Bioactive fungal polysaccharides as potential functional ingredients in food and nutraceuticals .Current Opinion in Biotechnology. 2014. Vol. 26. pp. 162-173. DOI: 10.1016/j.copbio.2014.01.010
25. Lavelli V. et al. Circular reuse of bio-resources: The role of: Pleurotus spp. in the development of functional foods. Food & Function. 2018. Vol. 9. No. 3. pp. 1353-1372. DOI: 10.1039/C7FO01747B
26. Khan M.A., Tania M. Nutritional and Medicinal Importance of Pleurotus Mushrooms: An Overview. Food Reviews International. 2012. Vol. 28. No. 3. pp. 313–329. DOI: 10.1080/87559129.2011.637267
27. Shamtsyan M. et al. Hyperlipidemic and hypocholesterolic action of submerge cultured mushrooms. Journal of Hygienic Engineering and Design. 2014. Vol. 7. pp. 96-99
28. Kozarski M. et al. Antioxidants of edible mushrooms. Molecules. 2015. Vol. 20. No. 10. p. 19489-19525. DOI: 10.3390/molecules201019489
29. Facchini J.M. et al. Antitumor activity of Pleurotus ostreatus polysaccharide fractions on Ehrlich tumor and Sarcoma 180. International journal of biological macromolecules. 2014. Vol. 68. pp. 72-77. DOI: 10.1016/j.ijbiomac.2014.04.033
30. Du B. et al. An insight into anti-inflammatory effects of fungal beta-glucans. Trends in Food Science & Technology. 2015. Vol. 41. No. 1. pp. 49-59. DOI: 10.1016/j.tifs.2014.09.002
31. Llauradó G. et al. Haematopoiesis radioprotection in Balb/c mice by an aqueous mycelium extract from the Basidiomycete Pleurotus ostreatus mushroom. Natural product research. 2015. Vol. 29. No. 16. pp. 1557-1561. DOI: 10.1080/14786419.2014.983918
32. Hozova B., Kuniak L., Kelemenova B. Application of beta-D-glucans isolated from mushrooms Pleurotus ostreatus (Pleuran) and Lentinus edodes (Lentinan) for increasing the bioactivity of yoghurts. Czech Journal of Food Sciences-UZPI (Czech Republic). 2004. Vol. 22. No. 6. pp. 204-214
33. Vital A.C.P. et al. Microbiological, functional and rheological properties of low fat yogurt supplemented with Pleurotus ostreatus aqueous extract. LWT-Food Science and Technology. 2015. Vol. 64. No. 2. pp. 1028-1035. DOI: 10.1016/j.lwt.2015.07.003
34. Антонцева Е. В. и др. Подбор условий глубинного культивирования Pleurotus ostreatus // Вестник Международной академии холода. 2019. № 1. С. 34–38. [Antontceva et al. Selection of conditions for submerged cultivation of Pleurotus ostreatus .Vestnik Mezhdunarodnoi akademii kholoda. 2019. No 1. pp. 34-38. (in Russian)]
35. Antontceva E. et al. Influence of Pleurotus ostreatus preparations on fermentation products of lactic acid cultures. Journal of Hygienic Engineering and Design. 2018. Vol. 22. pp. 47-52.
36. McCleary B. V., Draga A. Measurement of β-glucan in mushrooms and mycelial products. Journal of AOAC International. 2016. Vol. 99. No. 2. pp. 364-373. DOI: 10.5740/jaoacint.15-0289
37. Furman B.L. Streptozotocin-induced diabetic models in mice and rats. Current protocols in pharmacology. 2015. Vol. 70. No. 1. 5.47. pp.1-20. DOI: 10.1002/0471141755.ph0547s70
38. Onyango A.N. Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance. Oxidative medicine and cellular longevity. 2018. Vol. 2018. pp. 1-27. DOI: 10.1155/2018/4321714
39. Bobek P., Galbavy S. Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon. British journal of biomedical science. 2001. Vol. 58. No. 3. pp. 164-168
40. Du B., Bian Z., Xu B. Skin health promotion effects of natural beta-glucan derived from cereals and microorganisms: a review. Phytotherapy Research. 2014. Vol. 28. No. 2. pp. 159-166. DOI: 10.1002/ptr.4963
English
Русский
